Showing 11,521 - 11,540 results of 100,843 for search '(( 5 a decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (mean decrease)) ))', query time: 1.84s Refine Results
  1. 11521
  2. 11522
  3. 11523
  4. 11524
  5. 11525

    RLIPC elevates ST segment prior to induction of cardiac ischemia in rat model of arrhythmia. by Zhaoyang Hu (312662)

    Published 2016
    “…LVSP, left ventricular systolic pressure; LVEDP, left ventricular end-diastolic pressure; ±dP/dtmax, maximum rate of increase/decrease in left ventricular pressure. Data are the mean±SEM (<i>n = 6–7</i> in each group). …”
  6. 11526
  7. 11527

    Decreased branching, partial right isomerization and epithelial proximalization in CKO lungs. by Stijn P. De Langhe (38981)

    Published 2008
    “…<p>(a–d) β-gal staining of <i>Dermo1<sup>Cre/+</sup>/Rosa26R</i> WT lungs at E11.5 and E13.5 reports Cre recombination activity in the mesenchyme of the embryonic lung. …”
  8. 11528
  9. 11529
  10. 11530
  11. 11531
  12. 11532

    Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-s... by Sanne Verdoorn (6680822)

    Published 2019
    “…Over 6 months, in the intervention group, HR-QoL measured with EQ-VAS increased by 3.4 points (95% confidence interval [CI] 0.94 to 5.8; <i>p</i> = 0.006), and the number of health problems with impact on daily life decreased by 12% (difference at 6 months −0.34; 95% CI −0.62 to −0.044; <i>p</i> = 0.024) as compared with the control group. …”
  13. 11533
  14. 11534

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”
  15. 11535
  16. 11536
  17. 11537
  18. 11538
  19. 11539

    Expression of <i>Foxf1a</i> and <i>Foxf2</i> in <i>shh<sup>−/−</sup></i> and <i>Tbx5<sup>+/−</sup></i> mutants embryos at E9.5. by Andrew D. Hoffmann (651875)

    Published 2014
    “…<i>Tbx5</i> heterozygotes expressed <i>Foxf1a</i> at decreased levels specifically in the posterior SHF tissues (C, D), whereas <i>Foxf2</i> expression patterns were unchanged (G, H). …”
  20. 11540